[{"NetIncomeLoss_2_FY_USD":-123046.0,"PreferredStockSharesOutstanding_0_FY_shares":null,"GeneralAndAdministrativeExpense_2_FY_USD":108865.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_FY_shares":16675000.0,"CommitmentsAndContingencies_0_FY_USD":null,"InterestIncomeOther_2_FY_USD":65246.0,"AccruedLiabilitiesCurrent_0_FY_USD":74927.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts_2_FY_USD":-9624742.0,"NetCashProvidedByUsedInInvestingActivities_2_FY_USD":-166750000.0,"StockIssuedDuringPeriodValueNewIssues_2_FY_USD":25000.0,"AccruedIncomeTaxes_0_FY_USD":6864.0,"CurrentFederalTaxExpenseBenefit_2_FY_USD":6864.0,"AssetsCurrent_0_FY_USD":1497581.0,"SaleOfStockConsiderationReceivedPerTransaction_2_FY_USD":40000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_FY_USD":157362210.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":31362.0,"ProceedsFromRelatedPartyDebt_2_FY_USD":25.0,"ProceedsFromRepaymentsOfRelatedPartyDebt_2_FY_USD":-127232.0,"Liabilities_0_FY_USD":5950604.0,"AdditionalPaidInCapitalCommonStock_0_FY_USD":5122484.0,"RestrictedInvestmentsPercentOfNetAssets_0_FY_pure":0.2,"IncreaseDecreaseInAccruedLiabilities_2_FY_USD":4927.0,"IncomeTaxExpenseBenefit_2_FY_USD":6864.0,"CommonStockValue_0_FY_USD":564.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_FY_USD":1314085.0,"EffectiveIncomeTaxRateContinuingOperations_2_FY_pure":-0.0591,"StockIssuedDuringPeriodSharesIssuedForServices_2_FY_shares":25000000.0,"AssetsHeldInTrustNoncurrent_0_FY_USD":166815235.0,"ProceedsFromIssuanceOfPrivatePlacement_2_FY_USD":5335000.0,"NetCashProvidedByUsedInFinancingActivities_2_FY_USD":168391508.0,"StockIssuedDuringPeriodValueOther_2_FY_USD":166750000.0,"TemporaryEquityShareSubscriptions_0_FY_shares":15736221.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_2_FY_USD":null,"PaymentsOfStockIssuanceCosts_2_FY_USD":3591285.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":1314085.0,"Cash_0_FY_USD":1300000.0,"CurrentStateAndLocalTaxExpenseBenefit_2_FY_USD":null,"SaleOfStockPricePerShare_0_FY_USD":10.0,"CommonStockSharesIssued_0_FY_shares":5641029.0,"DebtInstrumentUnusedBorrowingCapacityFee_2_FY_USD":127000.0,"StockholdersEquity_0_FY_USD":5000002.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":31262.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-123046.0,"DebtInstrumentConvertibleConversionPrice1_0_FY_USD":10.0,"DeferredTaxAssetsGross_0_FY_USD":31262.0,"CommonStockSharesOutstanding_0_FY_shares":5641029.0,"DeferredFederalIncomeTaxExpenseBenefit_2_FY_USD":-31262.0,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2_FY_pure":-0.2691,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_FY_USD":-116182.0,"NetCashProvidedByUsedInOperatingActivities_2_FY_USD":-327423.0,"LiabilitiesCurrent_0_FY_USD":114354.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_FY_pure":0.21,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_2_FY_USD":40000.0,"PreferredStockSharesIssued_0_FY_shares":null,"EarningsPerShareBasicAndDiluted_2_FY_USD":0.0,"CashFDICInsuredAmount_0_FY_USD":250000.0,"SharePrice_0_FY_USD":0.35,"DeferredTaxAssetsValuationAllowance_0_FY_USD":31262.0,"Assets_0_FY_USD":168312816.0,"StockRedeemedOrCalledDuringPeriodValue_2_FY_USD":157362210.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_2_FY_USD":25000.0,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.0001,"DeferredTaxAssetsNet_0_FY_USD":null,"IncreaseDecreaseInAccruedTaxesPayable_2_FY_USD":6864.0,"PrepaidExpenseCurrent_0_FY_USD":183496.0,"CommonStockSharesAuthorized_0_FY_shares":30000000.0,"ProceedsFromIssuanceInitialPublicOffering_2_FY_USD":166750000.0,"BusinessCombinationConsiderationTransferred1_2_FY_USD":1500000.0,"PreferredStockValue_0_FY_USD":null,"DeferredIncomeTaxExpenseBenefit_2_FY_USD":6864.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":168312816.0,"PreferredStockSharesAuthorized_0_FY_shares":1000000.0,"BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_0_FY_pure":1.0,"OperatingIncomeLoss_2_FY_USD":-181428.0,"IncreaseDecreaseInPrepaidExpense_2_FY_USD":183496.0,"Ticker":"TNGX","CIK":"1819133","name":"BCTG ACQUISITION CORP.","OfficialName":"Tango Therapeutics Inc.","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"650767383.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210331"}]